Generic name: risedronate sodium
Dosage form: tablet, delayed release
This dosage information does not include all the information needed to use Atelvia safely and effectively. See full prescribing information for Atelvia.
The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.
Atelvia should be taken in the morning immediately following breakfast.
When compared with immediate-release risedronate, treatment with Atelvia resulted in a significantly higher incidence of abdominal pain when administered before breakfast under fasting conditions. Atelvia should be taken immediately following breakfast and not under fasting conditions.
To facilitate delivery to the stomach, Atelvia should be swallowed whole while the patient is in an upright position and with at least 4 ounces of plain water. Tablets should not be chewed, cut, or crushed. Patients should not lie down for 30 minutes after taking the medication [see Warnings and Precautions (5.2)].
Patients should receive supplemental calcium and vitamin D [see Warnings and Precautions (5.3)]. Calcium supplements, antacids, magnesium-based supplements or laxatives, and iron preparations interfere with the absorption of Atelvia and it is recommended they be taken at a different time of the day. Atelvia is not recommended for use in patients with severe renal impairment (creatinine clearance <30 mL/min) because of lack of clinical experience. No dosage adjustment is necessary in patients with a creatinine clearance ≥30 mL/min or in the elderly.
Treatment of Postmenopausal Osteoporosis
[see Indications and Usage (1.1)]
The recommended regimen is:
- one 35 mg delayed-release tablet orally, taken once-a-week